{"name":"NatureWise Biotech & Medicals Corporation","slug":"naturewise-biotech-medicals-corporation","ticker":"","exchange":"","domain":"","description":"NatureWise Biotech & Medicals Corporation is a biotechnology company focused on developing innovative therapies. The company currently has one drug in Phase 1 clinical trials, demonstrating its commitment to advancing medical treatments.","hq":"","founded":0,"employees":"Unknown","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE0xb0pISEh4ZjcwUFZZTE5odDA5bG9hdndLamhsSXdvb0RHdlBJeG5TWjluRjhTWHVqWE50YnpvWXRrTmhvNC1Lal8wNlBvMDBlTUM0WThtT3l6Q1d4M1FpQS1CZw?oc=5","date":"2026-04-02","type":"pipeline","source":"GuruFocus","summary":"Asia Stocks: Research Stocks from Asia Stock Market - GuruFocus","headline":"Asia Stocks: Research Stocks from Asia Stock Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9QQ3h3WDAwWHNldjNOQ21FSFFHcEtUTXVLaEhLajlUYkdzYlpPYXp6cVJfUnB3UzF2Wm9iQkhfRjJxMm9ibTZETkVXakp4Q00wS0hwSUFpdmlKeWN5OHZoQTFZdmhadTBSa0E?oc=5","date":"2020-08-04","type":"pipeline","source":"pharmexec.com","summary":"Taiwan: Pharma at the Tipping Point - pharmexec.com","headline":"Taiwan: Pharma at the Tipping Point","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}